| Nov 12 |
Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024
|
| Nov 10 |
Is Viking Therapeutics a Buy on the Dip?
|
| Nov 8 |
4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move
|
| Nov 7 |
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag
|
| Nov 5 |
Viking Therapeutics Offers An Obesity Drug for Healthy Adults
|
| Nov 5 |
Viking stock fluctuates amid manufacturing concerns with obesity pill
|
| Nov 5 |
Wall Street Breakfast Podcast: Debt Weighs On Voters On Election Day
|
| Nov 5 |
Is Viking Therepautics a Buy Now?
|
| Nov 4 |
Why Viking Therapeutics Stock Plummeted After Soaring Today
|
| Nov 4 |
Viking Therapeutics stock falling amid results for new GLP-1 pill
|
